Drugs & Medical Devices

Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.



Issue #7, July 2002

Court Rules Nature of Ephedra Class Action Relieves Insurer's Duty to Defend

A California appeals court has held that an insurer does not have a duty to defend the manufacturer of Metabolife 356 in a class action filed against the company because the underlying third-party complaint does not allege

Court Reverses Order to Quash Subpoenas of Treating Physicians in Ephedra Wrongful Death Case

A New York court has ruled that the testimony of doctors who treated a woman who died after taking an ephedra-containing product is material and necessary to resolve a lawsuit filed

Judge Rules on Defendant's <i>Daubert</i> Motion, Allows <br>Expert Witnesses to Testify in Alabama Ephedra Case

A federal judge has denied a defense motion to preclude the testimony of two expert witnesses in a lawsuit against the manufacturers of an ephedra-containing Metabolife product

Judge Grants Motion to Stay Baycol Class Action, Cites Inability to Estimate Value of Medical Monitoring Claims

The inability to estimate the value of medical monitoring claims as a whole was the basis for a federal judge's recent decision to grant a motion to stay proceedings in a Baycol products liability class action

Federal Judge Rules Plaintiff Complaint Lacks Cause of Action; Dismisses Case

A Louisiana woman's products liability lawsuit against the manufacturers of products containing PPA has been dismissed by a federal judge who decided the plaintiff failed to include causes of action

Judge Rules PPA Allegations Are Beyond Scope of Products Liability Act

A federal judge in Louisiana has dismissed two cases against the manufacturers of products containing PPA, stating the plaintiffs' allegations are ''well outside'' the scope

Federal Government Announces Plans for Ephedra Research

The U.S. Department of Health and Human Services has announced plans for a new study concerning the safety of ephedra and an increased effort to restrict the illegal sale of products containing synthetic ephedrine

New Celebrex Label To Warn of Renal Events; Gastrointestinal Benefit Claim Removed

The new FDA-approved warning labels accompanying the arthritis drug Celebrex will continue to educate patients and physicians of the potential risk of gastrointestinal events associated with the anti-inflammatory drug, and include new information for elde

Federal Judge Rules Responsive Pleading Too Ambiguous; Reprimands Attorneys for GlaxoSmithKline

A federal judge issued a scathing memorandum directed at attorneys for GlaxoSmithKline, noting discrepancies of its responsive pleading to a products liability action involving the drug Baycol.

Burden to Prove Jurisdiction Too Heavy for Lotronex Defendant; Judge Remands Case

A federal judge has granted a motion to remand a Lotronex product liability suit after finding that the defendants failed to conclusively prove the existence of federal jurisdiction and fraudulent joinder among non-diverse defendants in a lawsuit against

Past Issues:


The HarrisMartin VerdicTrack lets you track verdicts by product, state, defendant, or expert.